4536:TYO
Santen Pharmaceutical Co Ltd
1 734,00 JP¥
arrow_upward
+0,73%(+12,50) 1D
23 հոկ, 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4536...
Open
1 754 JP¥
High
1 761 JP¥
Low
1 734 JP¥
Mkt. cap
558,89 մլրդ
Avg. vol.
1,28 մլն
Volume
1,14 մլն
Dividend
2,19%
Quarterly dividend
10 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
14,47
52-wk high
2 254 JP¥
52-wk low
1 458 JP¥
EPS
120 JP¥
Shares outstanding
407,09 մլն
No. of employees
4 հզր
Open
1 754 JP¥
High
1 761 JP¥
Low
1 734 JP¥
Mkt. cap
558,89 մլրդ
Avg. vol.
1,28 մլն
Volume
1,14 մլն
Dividend
2,19%
Quarterly dividend
10 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
14,47
52-wk high
2 254 JP¥
52-wk low
1 458 JP¥
EPS
120 JP¥
Shares outstanding
407,09 մլն
No. of employees
4 հզր
News stories
From web sources and news partners
NDTV Profit
·
1 ժամ առաջ
19 For 19: Wall Street's Favourite Election Stat Meets A Fed That Has Barely Started
Yardeni QuickTakes
·
3 ժամ առաջ
US MARKETS CALL: Still Proceeding Cautiously
Investor's Business Daily
·
3 ժամ առաջ
What To Do In A Doom-And-Bloom Market; 3 Titans Loom
Profile
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
About Santen Pharmaceutical Co Ltd
CEOAkira Kurokawa | Shigeo Taniuchi
Employees3,97 հզր
Founded1890
HeadquartersՕսակա, Kansai, Ճապոնիա
Sector-
Websitesanten.com